Literature DB >> 32398281

COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.

Emanuele Bozzalla Cassione1,2, Giovanni Zanframundo1,2, Alessandro Biglia1,2, Veronica Codullo1,2, Carlomaurizio Montecucco3,2, Lorenzo Cavagna1,2.   

Abstract

Entities:  

Keywords:  epidemiology; hydroxychloroquine; lupus erythematosus, systemic

Mesh:

Substances:

Year:  2020        PMID: 32398281     DOI: 10.1136/annrheumdis-2020-217717

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  27 in total

1.  Training the trainees: COVID-19 and rheumatologists of the future.

Authors:  Hannah Jethwa; Sonya Abraham
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

2.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

Review 3. 

Authors:  Timo Buhl; Stefan Beissert; Evelyn Gaffal; Matthias Goebeler; Michael Hertl; Cornelia Mauch; Kristian Reich; Enno Schmidt; Michael P Schön; Michael Sticherling; Cord Sunderkötter; Claudia Traidl-Hoffmann; Thomas Werfel; Dagmar Wilsman-Theis; Margitta Worm
Journal:  J Dtsch Dermatol Ges       Date:  2020-08       Impact factor: 5.584

4.  Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs.

Authors:  Behnaz Yousefghahari; Sanaz Navari; Mahmoud Sadeghi; Shima Soleimaniamiri; Mohammadjafar Soleimaniamiri; Behzad Heidari; Mansour Babaei; Kian Ghodrati; Ardeshir Guran; Hemmat Gholinia
Journal:  Clin Rheumatol       Date:  2021-05-29       Impact factor: 2.980

5.  Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy.

Authors:  Pamela Vezzoli; Marco Di Mercurio; Andrea Carugno; Daniele Mario Gambini; Elisa Robustelli Test; Gianlorenzo Imberti; Angelo Francesco Castagna; Paolo Sena
Journal:  Dermatol Ther       Date:  2020-07-03       Impact factor: 3.858

6.  Telemedicine in rheumatology: a reliable approach beyond the pandemic.

Authors:  Lorenzo Cavagna; Giovanni Zanframundo; Veronica Codullo; Maria Grazia Pisu; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

Review 7.  COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience.

Authors:  Soraya Shadmanfar; Nematollah Jonaidi-Jafari; Ramezan Jafari; Zeynab Rastgar-Moqaddam; Amin Saburi
Journal:  Clin Rheumatol       Date:  2020-11-20       Impact factor: 2.980

8.  Cutaneous autoimmune diseases during COVID-19 pandemic.

Authors:  C Günther; R Aschoff; S Beissert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228

Review 9.  Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?

Authors:  Stephan Grabbe; Stefan Beissert; Alexander Enk
Journal:  J Dtsch Dermatol Ges       Date:  2020-08-02       Impact factor: 5.231

10.  Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.

Authors:  Carlo Salvarani; Pamela Mancuso; Federica Gradellini; Nilla Viani; Paolo Pandolfi; Massimo Reta; Giuliano Carrozzi; Gilda Sandri; Gianluigi Bajocchi; Elena Galli; Francesco Muratore; Luigi Boiardi; Nicolò Pipitone; Giulia Cassone; Stefania Croci; Anna Maria Marata; Massimo Costantini; Paolo Giorgi Rossi
Journal:  Arthritis Rheumatol       Date:  2020-11-27       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.